These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2449551)

  • 21. Polymorphonuclear leukocyte function in burned patients: effect of isoprinosine.
    Lazzarin A; Capsoni F; Zocchi MR; Candiani P; Signorini M; Moroni M; Donati L
    Panminerva Med; 1983; 25(3):173-80. PubMed ID: 6199716
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
    Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
    Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoprinosine therapy and SSPE.
    Huttenlocker PR
    Ann Neurol; 1980 Dec; 8(6):642. PubMed ID: 6163393
    [No Abstract]   [Full Text] [Related]  

  • 24. [Superficial herpetic keratitis : comparative treatment with trifluorothymidine or the combination isoprinosine-trifluorothymidine].
    Colin J; Bonissent JF; Renard G
    Bull Soc Ophtalmol Fr; 1982; 82(6-7):779-81. PubMed ID: 6184179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Attempted therapy of rheumatoid polyarthritis with isoprinosine. Results of an open study of 14 patients].
    Segond P; Sallière D; Clerc D; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1982 Jan; 49(1):45-9. PubMed ID: 6176009
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection.
    Ragni MV; Ruben FL; Winkelstein A; Spero JA; Bontempo FA; Lewis JH
    J Lab Clin Med; 1987 May; 109(5):545-9. PubMed ID: 3572201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic experiences with the immunostimulator inosine pranobex].
    Darlath W; Wybran J
    Fortschr Med; 1984 Oct; 102(37):932-4. PubMed ID: 6209193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphocyte populations in hemophilia A and B. Relation to acquired immunodeficiency syndrome and therapeutic implications].
    Vicente V; San Miguel JF; González M; Alberca I; Caballero MD; Rodríguez C; López Borrasca A
    Sangre (Barc); 1983; 28(3):318-29. PubMed ID: 6623294
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
    Inagaki T; Morise K; Matsunaga H
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):319-24. PubMed ID: 3257678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392.
    O'Neill BB; Ginsberg T; Hadden J
    Prog Clin Biol Res; 1984; 161():525-41. PubMed ID: 6207547
    [No Abstract]   [Full Text] [Related]  

  • 32. Perspectives on the immunotherapy of AIDS.
    Hadden JW
    Ann N Y Acad Sci; 1984; 437():76-87. PubMed ID: 6085453
    [No Abstract]   [Full Text] [Related]  

  • 33. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS; Risk WS
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination use of lentinan with X-ray therapy in a mouse experimental tumor system (Part I). Basic studies].
    Shiio T; Tsuchiya Y; Ohishi K; Yoshihama T
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):313-7. PubMed ID: 3341791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response in thermally injured guinea-pigs treated with methisoprinol.
    Castelli A; Sbano E; Fimiani M; Francini G; Andreassi L; Gennari C
    Int J Tissue React; 1984; 6(2):123-6. PubMed ID: 6203860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T-lymphocyte subpopulations in hemophiliacs and other groups at risk for the acquired immunodeficiency syndrome (AIDS)].
    Gallart T
    Med Clin (Barc); 1984 Oct; 83(12):492-6. PubMed ID: 6096646
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemophilia and AIDS].
    Marbet GA
    Schweiz Rundsch Med Prax; 1989 Jan; 78(1-2):3-4. PubMed ID: 2492672
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of topical methisoprinol (Viruxan) in female genital condylomatosis].
    Penna C; Fallani MG; Cariti G; Menichetti M; Bracco GL; Bellanti G; Cioffi M; Marchionni M
    Minerva Ginecol; 1989 Jan; 41(1):27-32. PubMed ID: 2472583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro restoration by interleukin-2 (IL-2) of the impaired natural killer cell activities, IL-2 receptor expression, and T cell proliferation in hemophilia.
    Zaizov R; Cohen IJ; Luria D; Trainin N; Umiel T
    J Biol Response Mod; 1986 Aug; 5(4):339-50. PubMed ID: 3090209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.